BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4055541)

  • 1. WIN 51711, a new systematically active broad-spectrum antipicornavirus agent.
    McKinlay MA
    J Antimicrob Chemother; 1985 Sep; 16(3):284-6. PubMed ID: 4055541
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.
    Otto MJ; Fox MP; Fancher MJ; Kuhrt MF; Diana GD; McKinlay MA
    Antimicrob Agents Chemother; 1985 Jun; 27(6):883-6. PubMed ID: 2992365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoxazoles with antipicornavirus activity.
    Diana GD; McKinlay MA; Brisson CJ; Zalay ES; Miralles JV; Salvador UJ
    J Med Chem; 1985 Jun; 28(6):748-52. PubMed ID: 2989517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.
    Woods MG; Diana GD; Rogge MC; Otto MJ; Dutko FJ; McKinlay MA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2069-74. PubMed ID: 2559655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipicornavirus activity of tetrazole analogues related to disoxaril.
    Diana GD; Cutcliffe D; Volkots DL; Mallamo JP; Bailey TR; Vescio N; Oglesby RC; Nitz TJ; Wetzel J; Giranda V
    J Med Chem; 1993 Oct; 36(22):3240-50. PubMed ID: 8230114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
    Fox MP; Otto MJ; McKinlay MA
    Antimicrob Agents Chemother; 1986 Jul; 30(1):110-6. PubMed ID: 3019232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.
    Rozhon E; Cox S; Buontempo P; O'Connell J; Slater W; De Martino J; Schwartz J; Miller G; Arnold E; Zhang A
    Antiviral Res; 1993 May; 21(1):15-35. PubMed ID: 8391247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral discrimination and antipicornavirus activity of 6-oxazolinylisoflavan.
    Quaglia MG; Desideri N; Bossù E; Sestili I; Tomao P; Conti C; Orsi N
    Chirality; 1993; 5(5):356-8. PubMed ID: 8398593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of poliovirus uncoating by disoxaril (WIN 51711).
    Zeichhardt H; Otto MJ; McKinlay MA; Willingmann P; Habermehl KO
    Virology; 1987 Sep; 160(1):281-5. PubMed ID: 2820136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Picornavirus inhibitors: trifluoromethyl substitution provides a global protective effect against hepatic metabolism.
    Diana GD; Rudewicz P; Pevear DC; Nitz TJ; Aldous SC; Aldous DJ; Robinson DT; Draper T; Dutko FJ; Aldi C
    J Med Chem; 1995 Apr; 38(8):1355-71. PubMed ID: 7731021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [(Biaryloxy)alkyl]isoxazoles: picornavirus inhibitors.
    Guiles JW; Diana GD; Pevear DC
    J Med Chem; 1995 Jul; 38(14):2780-3. PubMed ID: 7629816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus.
    Diana GD; Cutcliffe D; Oglesby RC; Otto MJ; Mallamo JP; Akullian V; McKinlay MA
    J Med Chem; 1989 Feb; 32(2):450-5. PubMed ID: 2913305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of picornavirus uncoating as antiviral agents.
    Diana GD; Otto MJ; McKinlay MA
    Pharmacol Ther; 1985; 29(3):287-97. PubMed ID: 3014575
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus.
    Rossmann MG
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4625-7. PubMed ID: 3133655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipicornavirus activity of substituted phenoxybenzenes and phenoxypyridines.
    Markley LD; Tong YC; Dulworth JK; Steward DL; Goralski CT; Johnston H; Wood SG; Vinogradoff AP; Bargar TM
    J Med Chem; 1986 Mar; 29(3):427-33. PubMed ID: 3005578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and development of antipicornaviral agents.
    McKinlay MA
    Scand J Infect Dis Suppl; 1993; 88():109-15. PubMed ID: 8516662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipicornavirus activity of SCH 47802 and analogs: in vitro and in vivo studies.
    Cox S; Buontempo PJ; Wright-Minogue J; DeMartino JL; Skelton AM; Ferrari E; Schwartz J; Rozhon EJ; Linn CC; Girijavallabhan V; O'Connell JF
    Antiviral Res; 1996 Oct; 32(2):71-9. PubMed ID: 8891166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral agent blocks breathing of the common cold virus.
    Lewis JK; Bothner B; Smith TJ; Siuzdak G
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6774-8. PubMed ID: 9618488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
    Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
    Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on the antipicornavirus activity of flavonoid compounds (flavones) by using quantum chemical and chemometric methods.
    Souza J; Molfetta FA; Honório KM; Santos RH; da Silva AB
    J Chem Inf Comput Sci; 2004; 44(3):1153-61. PubMed ID: 15154785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.